Literature DB >> 19863345

A structured review and guide through studies on health-related quality of life in kidney cancer, hepatocellular carcinoma, and leukemia.

Jia Liu1, Thomas Mittendorf, J-Matthias von der Schulenburg.   

Abstract

Aim of this paper is to review and describe Health-Related Quality of Life (HRQoL) measures applied in kidney cancer, hepatocellular carcinoma, and leukemia patients under drug therapy. A comprehensive search in PubMed was conducted to identify studies assessing quality of life (QoL) in these indications. In total 32 studies, including four studies through reference list checking and 21 different HRQoL instruments, were identified. Six generic, five disease-specific, and 10 domain-specific instruments were identified. In conclusion no overall standards in HRQoL measurement could be observed in the respective indications.

Entities:  

Mesh：

Year:  2010        PMID： 19863345     DOI： 10.3109/07357900903287022

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


  7 in total

Review 1.  Beyond traditional outcomes: improving quality of life in patients with renal cell carcinoma.

Authors:  David Cella
Journal:  Oncologist       Date:  2011

Review 2.  Targeted therapies for non-clear renal cell carcinoma.

Authors:  Eric A Singer; Gennady Bratslavsky; W Marston Linehan; Ramaprasad Srinivasan
Journal:  Target Oncol       Date:  2010-08-03       Impact factor: 4.493

3.  Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia.

Authors:  Chris L Pashos; Christopher R Flowers; Neil E Kay; Mark Weiss; Nicole Lamanna; Charles Farber; Susan Lerner; Jeff Sharman; David Grinblatt; Ian W Flinn; Mark Kozloff; Arlene S Swern; Thomas K Street; Kristen A Sullivan; Gale Harding; Zeba M Khan
Journal:  Support Care Cancer       Date:  2013-06-08       Impact factor: 3.603

Review 4.  A closer look at quality of life in the hepatocellular carcinoma literature.

Authors:  Jenny L Firkins; Robin Tarter; Martha Driessnack; Lissi Hansen
Journal:  Qual Life Res       Date:  2021-02-24       Impact factor: 4.147

5.  Sunitinib in metastatic renal cell carcinoma (mRCC): a developing country experience. Do our patients behave differently than the Western patients?

Authors:  Mohmad Hussain Mir; Khalid Hamid Changal; Shiekh Aejaz Aziz; Gull Mohammad Bhat; Abdul Rashid Lone
Journal:  Int Urol Nephrol       Date:  2016-07-23       Impact factor: 2.370

6.  Health-related quality of life questionnaires in lung cancer trials: a systematic literature review.

Authors:  Kathrin Damm; Nicole Roeske; Christian Jacob
Journal:  Health Econ Rev       Date:  2013-05-16

7.  Basic issues concerning health-related quality of life.

Authors:  Roman Sosnowski; Marta Kulpa; Urszula Ziętalewicz; Jan Karol Wolski; Robert Nowakowski; Robert Bakuła; Tomasz Demkow
Journal:  Cent European J Urol       Date:  2017-04-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.